Ouhoe Clearface Overnight Acne

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage guidelines provided for this medication.

There are no known teratogenic effects associated with this drug, nor are there any reported nonteratogenic effects. Healthcare professionals should consider these factors when evaluating the appropriateness of this drug for individual patients.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is clean and dry prior to application. A piece of the product should be taken and adhered to the affected area where acne is present. The product should remain in place for a duration of six hours before being removed.

Contraindications

There are no identified contraindications for this product. It is not classified as a controlled substance, and there are no associated risks of abuse, misuse, or dependence.

Discontinue use if signs of irritation or rash occur.

Warnings and Precautions

It is imperative to keep this product out of reach of children to prevent accidental ingestion or misuse. The product is not intended for oral consumption; therefore, it should not be swallowed under any circumstances.

To ensure optimal efficacy and safety, healthcare professionals are advised to instruct patients to thoroughly clean their hands prior to application. This practice is essential for achieving the best results from the product.

In the event that any signs of irritation or rash develop during use, it is crucial to discontinue application immediately. Monitoring for these adverse reactions is recommended to ensure patient safety and to facilitate timely intervention if necessary.

Side Effects

Patients should be advised to discontinue use if signs of irritation or rash occur. It is important to keep the product out of reach of children and to avoid swallowing. To ensure optimal results, patients are encouraged to clean their hands before use. Additionally, the product should be stored in a cool and dry place to maintain its efficacy.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ouhoe Clearface Overnight Acne (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. There are no specific age ranges, dosage differences, or study outcomes provided for pediatric use in the available data. Caution is advised when administering this medication to ensure safety in the pediatric population.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There is no information available regarding the use of this drug in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

The evaluation of nonclinical toxicology has revealed no evidence of teratogenic effects associated with the compound. Additionally, there are no reported non-teratogenic effects observed in the studies conducted. Comprehensive assessments in animal pharmacology and toxicology have also indicated an absence of significant findings. Overall, the data supports a favorable safety profile in the context of nonclinical studies.

Postmarketing Experience

No postmarketing experience has been reported.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion or misuse. It is important to inform patients that they should discontinue use immediately if any signs of irritation or rash occur, as this may indicate an adverse reaction to the product. Additionally, patients should be instructed to clean their hands thoroughly before using the product to ensure optimal results and maintain hygiene.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool and dry place to maintain its integrity and effectiveness. Proper storage conditions are crucial to ensure the product remains within its specified quality parameters.

Additional Clinical Information

The product is administered topically. Patients should first clean and dry the affected skin area before applying a piece of the product directly onto the acne. It is recommended to leave the product in place for six hours before removal.

Clinicians should advise patients to keep the product out of reach of children and to avoid swallowing it. Patients are encouraged to wash their hands prior to application to optimize results. If any signs of irritation or rash occur, use should be discontinued. Additionally, the product should be stored in a cool, dry place.

Drug Information (PDF)

This file contains official product information for Ouhoe Clearface Overnight Acne, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)